IPP Bureau
BrePco Biopharma and Piramal Critical Care announce MHRA approval for Neoatricon in UK
By IPP Bureau - March 21, 2025
PCC has secured the commercialization rights for the EU, UK, and Norway and will be responsible for distributing Neoatricon in these regions
Lucas Meyer Cosmetics introduces GlowCytocin to capture the science of “Love Glow”
By IPP Bureau - March 20, 2025
First-of-its-kind active cosmetic ingredient directly activates the oxytocin receptor, mimicking the dermatological effects of being in love
Zota Health Care expands Davaindia network to 1,530 stores
By IPP Bureau - March 20, 2025
The company has also launched its first three 24*7 pharmacy stores via COCO model in Bengaluru
USFDA grants Priority Review for new indication of finerenone for patients with common heart failure
By IPP Bureau - March 20, 2025
Finerenone is the first drug targeting the mineralocorticoid receptor (MR) pathway to demonstrate cardiovascular benefits in a Phase III study in patients with heart failure
Syngene concludes acquisition of biologics manufacturing facility from Emergent BioSolutions
By IPP Bureau - March 20, 2025
The new site will increase Syngene's total single-use bioreactor capacity to 50,000L
ZIM Laboratories receives marketing authorization for Dimethyl Fumarate in Portugal
By IPP Bureau - March 20, 2025
Dimethyl Fumarate Modified Release Capsules are indicated for the treatment of relapsing forms of multiple sclerosis
Briefs: Dr. Agarwal's Eye Hospital and Apitoria Pharma
By IPP Bureau - March 20, 2025
Apitoria Pharma’s API manufacturing facility classified as VAI by USFDA
Healthcare Triangle appoints Sujatha Ramesh as COO
By IPP Bureau - March 20, 2025
Previously, Sujatha has held leadership positions at prominent organizations, including Publicis Sapient, Infinite Computer Solutions, and Capgemini
UFlex’s FlexiTubes to showcase sustainable beauty packaging at COSMOPROF Italy 2025
By IPP Bureau - March 20, 2025
FlexiTubes will showcase range of eco-friendly and innovative tube options
Aerogen opens India HQ in New Delhi
By IPP Bureau - March 20, 2025
The new office in New Delhi marks a significant funding in the APAC region and reinforces the company’s commitment to advancing respiratory care in India
Croda opens advanced lipids manufacturing facility in Pennsylvania
By IPP Bureau - March 19, 2025
This facility represents a significant step in Croda’s Pharma business strategy to ‘Empower biologics delivery’
Financial Times names Indegene among high-growth companies in Asia-Pacific 2025
By IPP Bureau - March 19, 2025
Indegene combines deep healthcare expertise with a digital-first approach to help pharma, biotech and medical device companies commercialize their products
Zydus receives final approval from USFDA for Apalutamide Tablets, 60 mg
By IPP Bureau - March 19, 2025
Apalutamide is an androgen receptor inhibitor indicated for the treatment of patients with metastatic castration-sensitive prostate cancer














